Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) LT-Debt-to-Total-Asset : 0.28 (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Lotus Pharmaceutical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Lotus Pharmaceutical Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.28.

Lotus Pharmaceutical Co's long-term debt to total assets ratio declined from Mar. 2023 (0.32) to Mar. 2024 (0.28). It may suggest that Lotus Pharmaceutical Co is progressively becoming less dependent on debt to grow their business.

Lotus Pharmaceutical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Lotus Pharmaceutical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Pharmaceutical Co LT-Debt-to-Total-Asset Chart

Lotus Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.21

0.25

0.22

0.29

Lotus Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.32	0.26	0.26	0.29	0.28

Lotus Pharmaceutical Co LT-Debt-to-Total-Asset Calculation

Lotus Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	310.436	/	1055.68
	=	0.29

Lotus Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	304.051	/	1081.867
	=	0.28

Lotus Pharmaceutical Co (OTCPK:LTPCF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Lotus Pharmaceutical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Lotus Pharmaceutical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Pharmaceutical Co Ltd (OTCPK:LTPCF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

1795:Taiwan

Address

Song Ren Road, 17th Floor, No. 277, Xin Yi District, Taipei, TWN, 110

Website

https://www.lotuspharm.com.tw

Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. It is engaged in generic drug business segment, which engages mainly in the research and development, manufacturing and sales of generic pharmaceutical products. It has its geographic presence in United States, South Korea and Others.

Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Headlines

From GuruFocus

LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN ITS HISTORY

By PRNewswire PRNewswire • 11-11-2022